HIV-1 Nef plays an essential role in two independent processes in CD4 down-regulation: Dissociation of the CD4-p56(lck) complex and targeting of CD4 to lysosomes

Virology

Volumn 257, Issue 1, 1999, Pages 208-219

  Kim, Young Hoon ^a   Chang, Su Hwan ^a   Kwon, Jeong Ho ^a   Rhee, Sung S ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GENE PRODUCT; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; DOWN REGULATION; ENDOCYTOSIS; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYSOSOME; MONKEY; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROCESSING; VIRUS REPLICATION;

EID: 0345363092     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9642     Document Type: Article

References (49)

1. Aiken C., Konner J., Landau N. R., Lenburg M. E., Trono D. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 76:1994;853-864.
2. Aiken C., Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:1995;5048-5056.
3. Anderson S. J., Lenburg M., Landau N. R., Garcia J. V. The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef. J. Virol. 68:1994;3092-3101.
4. Aniento F., Gu F., Parton R. G., Gruenberg J. An endosomal βCOP is involved in the pH-dependent formation of transport vesicles destined for late endosomes. J. Cell Biol. 133:1996;29-41.
5. Arcaro A., Wymann M. P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: The role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses. Biochem. J. 296:1993;297-301.
6. Bandres J. C., Ratner L. Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. J. Virol. 68:1994;3243-3249.
7. Baur A. S., Sawai E. T., Dazin P., Fantl W. J., Cheng-Mayer C., Peterlin B. M. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity. 1:1994;373-384.
8. Benichou S., Bomsel M., Bodeus M., Durand H., Doute M., Letourneur F., Camonis J., Benarous R. Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J. Biol. Chem. 269:1994;30073-30076.
9. Benson R. E., Sanfridson A., Ottinger J. S., Doyle C., Cullen B. R. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 177:1993;1561-1566.
10. Chowers M. Y., Pandori M. W., Spina C. A., Richman D. D., Guatelli J. C. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology. 212:1995;451-457.
11. de Ronde A., Klaver B., Keulen W., Smit L., Goudsmit J. Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes. Virology. 188:1992;391-395.
12. Foti M., Mangasarian A., Piguet V., Lew D. P., Krause K. H., Trono D., Carpentier J. L. Nef-mediated clathrin-coated pit formation. J. Cell Biol. 139:1997;37-47.
13. Garcia J. V., Alfano J., Miller A. D. The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. J. Virol. 67:1993;1511-1516.
14. Garcia J. V., Miller A. D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature. 350:1991;508-511.
15. Goldsmith M. A., Warmerdam M. T., Atchison R. E., Miller M. D., Greene W. C. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69:1995;4112-4121.
16. Graziani A., Galimi F., Medico E., Cottone E., Gramaglia D., Boccaccio C., Comoglio P. M. The HIV-1 Nef protein interferes with phosphatidylinositol 3-kinase activation 1. J. Biol. Chem. 271:1996;6590-6593.
17. Greenberg M. E., Bronson S., Lock M., Neumann M., Pavlakis G. N., Skowronski J. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 16:1997;6964-6976.
18. Grzesiek S., Stahl S. J., Wingfield P. T., Bax A. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry. 35:1996;10256-10261.
19. Harris M. P., Neil J. C. Myristoylation-dependent binding of HIV-1 Nef to CD4. J. Mol. Biol. 241:1994;136-142.
20. Jamieson B. D., Aldrovandi G. M., Planelles V., Jowett J. B., Gao L., Bloch L. M., Chen I. S., Zack J. A. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68:1994;3478-3485.
21. Joly M., Kazlauskas A., Corvera S. Phosphatidylinositol 3-kinase activity is required at a postendocytic step in platelet-derived growth factor receptor trafficking. J. Biol. Chem. 270:1995;13225-13230.
22. Joly M., Kazlauskas A., Fay F. S., Corvera S. Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science. 263:1994;684-687.
23. Kestler H. W., Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65:1991;651-662.
24. Letourneur F., Klausner R. D. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell. 69:1992;1143-1157.
25. Li G., Souza-Schorey C., Barbieri M. A., Roberts R. L., Klippel A., Williams L. T., Stahl P. D. Evidence for phosphatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab5. Proc. Natl. Acad. Sci. USA. 92:1995;10207-10211.
26. Marsh M., Armes J. E., Pelchen-Matthews A. Endocytosis and recycling of CD4. Biochem. Soc. Trans. 18:1990;139-144.
27. Miller A. D., Rosman G. J. Improved retroviral vectors for gene transfer and expression. BioTechniques. 7:1989;980-990.
28. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C., Feinberg M. B. The human immunodeficiency virus-1 nef gene product: A positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:1994;101-113.
29. Opresko L. K. Endocytosis and lysosomal targeting of epidermal growth factor receptors are mediated by distinct sequences independent of the tyrosine kinase domain. J. Biol. Chem. 270:1995;4325-4333.
30. Pelchen-Matthews A., Armes J. E., Griffiths G., Marsh M. Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells. J. Exp. Med. 173:1991;575-587.
31. Pelchen-Matthews A., Armes J. E., Marsh M. Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells. EMBO J. 8:1989;3641-3649.
32. Pelchen-Matthews A., Boulet I., Littman D. R., Fagard R., Marsh M. The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits. J. Cell Biol. 117:1992;279-290.
33. Piguet V., Chen Y.-L., Mangasarian A., Foti M., Carpenter J.-L., Trono D. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the μ chain of adaptor complexes. EMBO J. 17:1998;2427-2481.
34. Rhee S. S., Marsh J. W. HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancement. J. Immunol. 152:1994a;5128-5134.
35. Rhee S. S., Marsh J. W. Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol. 68:1994b;5156-5163.
36. Robinson M. S., Watts C., Zerial M. Membrane dynamics in endocytosis. Cell. 84:1996;13-21.
37. Rossi F., Gallina A., Milanesi G. Nef-CD4 physical interaction sensed with the yeast two-hybrid system. Virology. 217:1996;397-403.
38. Schu P. V., Takegawa K., Fry M. J., Stack J. H., Waterfield M. D., Emr S. D. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science. 260:1993;88-91.
39. Schwartz O., Marechal V., Le Gall S., Lemonnier F., Heard J. M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:1996;338-342.
40. Schwartz O., Riviere Y., Heard J. M., Danos O. Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef. J. Virol. 67:1993;3274-3280.
41. Shaw A. S., Amrein K. E., Hammond C., Stern D. F., Sefton B. M., Rose J. K. The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain. Cell. 59:1989;627-636.
42. Shepherd P. R., Reaves B. J., Davidson H. W. Phosphoinositide 3-kinases and membrane traffic. Trends Cell Biol. 6:1996;92-97.
43. Skowronski J., Parks D., Mariani R. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:1993;703-713.
44. Spina C. A., Kwoh T. J., Chowers M. Y., Guatelli J. C., Richman D. D. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179:1994;115-123.
45. Thelen M., Wymann M. P., Langen H. Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. Proc. Natl. Acad. Sci. USA. 91:1994;4960-4964.
46. lckwith cytoplasmic domain of CD4 and CD8 is mediated by cysteine motifs. Cell. 60:1990;755-765.
47. Ward S. G., June C. H., Olive D. PI 3-kinase: A pivotal pathway in T-cell activation. Immunol. Today. 17:1996;187-197.
48. Whitman M., Kaplan D., Roberts T., Cantley L. Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation. Biochem. J. 247:1987;165-174.
49. Whitney J. A., Gomez M., Sheff D., Kreis T., Mellman I. Cytoplasmic coat proteins involved in endosome function. Cell. 83:1995;703-713.